# A Clinical Trial to Evaluate the Efficacy and Safety of DR-3001 in Women With Overactive Bladder

> **NCT00685113** · PHASE3 · COMPLETED · sponsor: **Duramed Research** · enrollment: 1104 (actual)

## Conditions studied

- Overactive Bladder

## Interventions

- **DRUG:** DR-3001
- **DRUG:** DR-3001
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00685113
- **Lead sponsor:** Duramed Research
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-05
- **Primary completion:** 2010-03
- **Final completion:** 2010-03
- **Target enrollment:** 1104 (ACTUAL)
- **Last updated:** 2016-07-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00685113

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00685113, "A Clinical Trial to Evaluate the Efficacy and Safety of DR-3001 in Women With Overactive Bladder". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT00685113. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*